rosiglitazone has been researched along with quercetin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kaushik, NK; Kohli, E; Kumari, R; Parmar, VS; Prasad, AK; Raj, HG; Rohil, V | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Deng, HW; Hu, CP; Li, YJ; Peng, SM; Tan, LF; Zou, XQ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
| Liang, YC; Lin, JK; Lin-Shiau, SY; Tsai, DC; Tsai, SH | 1 |
| Ha, JM; Kim, HK; Kim, KA; Park, JY; Park, PW | 1 |
| Fang, XK; Gao, J; Zhu, DN | 1 |
| Actis-Goretta, L; Beekmann, K; de Haan, LH; Rietjens, IM; Rubió, L; van Bladeren, PJ; van der Burg, B | 1 |
| Hosaka, S; Iwano, S; Iwasaki, K; Murayama, N; Satsukawa, M; Shimizu, M; Uehara, S; Uno, Y; Yamazaki, H | 1 |
| Dong, Z; Duan, H; Ji, X; Jiang, P; Li, M; Li, X; Ma, B; Ma, X; Ni, Z; Wang, B; Wei, Q | 1 |
1 review(s) available for rosiglitazone and quercetin
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |
1 trial(s) available for rosiglitazone and quercetin
| Article | Year |
|---|---|
Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C8; Half-Life; Humans; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Quercetin; Rosiglitazone; Thiazolidinediones | 2005 |
12 other study(ies) available for rosiglitazone and quercetin
| Article | Year |
|---|---|
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
Topics: Aflatoxin B1; Animals; Antimutagenic Agents; Bone Marrow Cells; Catalysis; Cytochrome P-450 Enzyme System; Male; Micronucleus Tests; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Quercetin; Rats; Rats, Wistar | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection.
Topics: Aldehyde Reductase; Cysteine; Flavonoids; Glycation End Products, Advanced; Hep G2 Cells; Humans; Nitric Oxide; Oxadiazoles; Vascular Diseases | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages.
Topics: Animals; Apigenin; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flavonoids; Genes, Reporter; Kaempferols; Macrophages; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Binding; Quercetin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Antioxidants; Cell Differentiation; Euonymus; Genes, Reporter; Glucose; Humans; Hypoglycemic Agents; Kaempferols; Macrophages, Peritoneal; Medicine, Chinese Traditional; Mice; Molecular Structure; Nitrites; Plant Extracts; PPAR gamma; Quercetin; Rosiglitazone; Thiazolidinediones | 2008 |
The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ).
Topics: Cell Line; Drug Synergism; Endpoint Determination; Gene Expression Profiling; Gene Expression Regulation; Genes, Reporter; Glucuronides; Humans; Kaempferols; Ligands; PPAR gamma; Quercetin; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2015 |
Identification of putative substrates for cynomolgus monkey cytochrome P450 2C8 by substrate depletion assays with 22 human P450 substrates and inhibitors.
Topics: Acetates; Amodiaquine; Animals; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Macaca fascicularis; Pharmaceutical Preparations; Quercetin; Quinolines; Rosiglitazone; Species Specificity; Substrate Specificity; Sulfides; Thiazolidinediones | 2016 |
Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Drinking Behavior; Feeding Behavior; Homeostasis; Insulin; Male; Metformin; Mice; Quercetin; Rosiglitazone; Spectrophotometry, Infrared; Thiazolidinediones; Trehalose; Vanadium | 2016 |